# Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study

> **NCT06464276** · — · COMPLETED · sponsor: **Ministry of Health, Brazil** · enrollment: 800 (actual)

## Conditions studied

- Chronic Coronary Syndrome
- Stable Angina

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06464276
- **Lead sponsor:** Ministry of Health, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-31
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06464276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06464276, "Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06464276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*